Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of Cynanoside H in preparation of drug for preventing and treating breast cancer

A technology of breast cancer, breast cancer cells, applied in the field of medicine

Active Publication Date: 2020-07-03
THE KEY LAB OF CHEM FOR NATURAL PROD OF GUIZHOU PROVINCE & CHINESE ACADEMY OF SCI
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Cynanoside H is a difidopregnane-type steroid compound isolated from the root of Baiwei root. It has been reported that Cynanoside H has significant anti-tobacco mosaic virus (TMV) activity, but there is no report about the pharmacological effects of Cynanoside H.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Cynanoside H in preparation of drug for preventing and treating breast cancer
  • Application of Cynanoside H in preparation of drug for preventing and treating breast cancer
  • Application of Cynanoside H in preparation of drug for preventing and treating breast cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Cell Viability Test

[0050] Collect logarithmic phase cells, MDA-MB-231 cells according to 6×10 3 The density of each well was planted in a 96-well plate and cultured overnight. After the cells adhered to the wall, they were treated with different concentrations of Cynanoside H (hereinafter referred to as BW18), and 0.1% DMSO was used as the control group. After 72 hours of drug action, add 20 μL of MTT with a concentration of 5 mg / mL to each well, incubate at 37°C for 4 hours, discard the supernatant, add 160 μL DMSO to each well to dissolve, and measure the absorbance value OD with a microplate reader after the blue-purple crystal formazan is completely dissolved. (490nm).

[0051] Calculation method of inhibition rate: inhibition rate=(OD490nm of control group-OD490nm of treatment group) / OD490nm of control group. half inhibition rate (IC 50 ) calculation method: use the forecast function to obtain the IC corresponding to the compound 50 .

[0052] The results s...

Embodiment 2

[0054] Observation of cell morphology

[0055] Collect logarithmic phase cells, MDA-MB-231 cells according to 4×10 3 The density of each well was planted in a 96-well plate and cultured overnight. After the cells adhered to the wall, high, medium and low (10 μM, 5 μM and 2.5 μM) concentrations of BW18 were added to treat MDA-MB-231 cells, and 0.1% DMSO for the control group. After 72 h, the morphological changes of the cells were observed.

[0056] The result is as figure 2 As shown, with the increase of BW18 concentration, the number of MDA-MB-231 cells decreased significantly. 5 μM and 10 μM BW18 significantly inhibited cell growth, and after BW18 acted on MDA-MB-231 cells, the cell shape changed from long spindle to round.

Embodiment 3

[0058] Cell Growth Curve Determination

[0059] Collect logarithmic phase cells, MDA-MB-231 cells according to 4×10 3 The density of cells / well was planted in a 96-well plate and cultured overnight. After the cells adhered to the wall, they were treated with high, medium and low (10 μM, 5 μM and 2.5 μM) concentrations of BW18 at 0 h, 12 h, 24 h, 36 h, respectively. OD490nm was measured at 48h, 72h and 96h, and the growth curve was drawn.

[0060] The result is as image 3 As shown, compared with the control group, different concentrations of BW18 can inhibit the proliferation of MDA-MB-231 cells, and with the increase of BW18 concentration, the growth rate of MDA-MB-231 cells gradually slowed down, indicating that BW18 can exhibit Inhibits the proliferation of MDA-MB-231 in a concentration- and time-dependent manner.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicines, in particular to an application of Cynanoside H in preparation of a drug for preventing and treating a breast cancer. A pharmacological studyshows that Cynanoside H inhibits MDA-MB-231 cell proliferation through inducing S-phase cycle arrest, reverses epithelial-mesenchymal transition to inhibit MDA-MB-231 cell migration and invasion, plays a role in preventing and treating the breast cancer, especially triple-negative breast cancer, and provides a new idea for research and development of the drug for preventing and / or treating the breast cancer.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to the application of Cynanoside H in the preparation of drugs for preventing and treating breast cancer. Background technique [0002] According to the Global Cancer Statistical Report (GLOBOCAN) released by the American Cancer Society, there were approximately 2.1 million new breast cancer cases worldwide in 2018, accounting for 11.6% of all new cancer cases, 24.2% of new cancer cases in women, and breast cancer deaths Accounting for 15% of female cancer deaths, it is the tumor disease with the highest morbidity and mortality among female cancers in the world. Breast cancer, like other tumors, is a heterogeneous disease with complex pathogenesis. At present, breast cancer treatment methods mainly include surgery, radiotherapy and chemotherapy, endocrine therapy and targeted therapy. But it is worth noting that triple-negative breast cancer patients account for about 15% of brea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61P35/00
CPCA61K31/7048A61P35/00
Inventor 杨珏李艳梅郝小江晏英邱剑飞饶青宋晶睿
Owner THE KEY LAB OF CHEM FOR NATURAL PROD OF GUIZHOU PROVINCE & CHINESE ACADEMY OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com